Michael Cohen New CEO of MetriGenix; Heidi Bullock Leaves Vitra Biosciences; Naveen Kulkarni Goes to Polyclone from SysArris; Ren Bernards Wins Spinoza Prize, Claire Fraser Receives Promega Biotech Research Award; and Others | GenomeWeb

Michael Cohen has become the new chief scientific officer of Toronto-based MetriGenix, following the acquisition of GeneXP Biosciences by MetriGenix,. He is the former president of GeneXP.


 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.